NNT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.513000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.451400E-01
Normal-vs-Stage2
4.473400E-01
Normal-vs-Stage3
1.473970E-01
Normal-vs-Stage4
9.942200E-01
Stage1-vs-Stage2
4.166400E-01
Stage1-vs-Stage3
9.675900E-03
Stage1-vs-Stage4
8.578800E-01
Stage2-vs-Stage3
4.9960036108132E-15
Stage2-vs-Stage4
3.786600E-01
Stage3-vs-Stage4
1.546390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.025200E-01
Normal-vs-AfricanAmerican
8.326600E-01
Normal-vs-Asian
6.700200E-01
Caucasian-vs-AfricanAmerican
2.117000E-01
Caucasian-vs-Asian
6.669600E-01
AfricanAmerican-vs-Asian
4.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.966600E-01
Normal-vs-Female
6.265800E-01
Male-vs-Female
7.155800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.787800E-01
Normal-vs-Age(41-60Yrs)
8.574600E-01
Normal-vs-Age(61-80Yrs)
4.177600E-01
Normal-vs-Age(81-100Yrs)
2.446400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.914400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.267600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.594400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.031220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.143600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.745400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.329180E-01
Normal-vs-Daily Drinker
1.746400E-01
Normal-vs-Weekly Drinker
6.304600E-01
Normal-vs-Occasional Drinker
7.610000E-01
Normal-vs-Social Drinker
9.658400E-01
Non Drinker-vs-Daily Drinker
9.204600E-01
Non Drinker-vs-Weekly Drinker
1.027030E-01
Non Drinker-vs-Occasional Drinker
1.185410E-01
Non Drinker-vs-Social Drinker
1.656150E-01
Daily Drinker-vs-Weekly Drinker
1.569610E-01
Daily Drinker-vs-Occasional Drinker
1.348810E-01
Daily Drinker-vs-Social Drinker
1.830160E-01
Weekly Drinker-vs-Occasional Drinker
8.734600E-01
Weekly Drinker-vs-Social Drinker
5.641600E-01
Occasional Drinker-vs-Social Drinker
6.455400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.181400E-01
Normal-vs-Grade 2
9.913600E-01
Normal-vs-Grade 3
9.596200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.025600E-01
Grade 1-vs-Grade 3
6.144400E-01
Grade 1-vs-Grade 4
8.181400E-01
Grade 2-vs-Grade 3
5.070600E-01
Grade 2-vs-Grade 4
9.913600E-01
Grade 3-vs-Grade 4
9.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.959600E-01
Normal-vs-NonDiabetic
5.534800E-01
Diabetic-vs-NonDiabetic
4.382200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.204400E-01
Normal-vs-NoPancreatitis
5.178800E-01
Pancreatitis-vs-NoPancreatitis
7.987600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.804400E-01
Normal-vs-N1
4.402200E-01
N0-vs-N1
3.730600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.990600E-01
Normal-vs-TP53-NonMutant
7.971800E-01
TP53-Mutant-vs-TP53-NonMutant
8.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
